Molecular Cancer Therapeutics (@mct_aacr) 's Twitter Profile
Molecular Cancer Therapeutics

@mct_aacr

The go-to journal for transitioning experimental therapies developed at the bench into clinical investigation, from preclinical study to phase I trials.

ID: 1021755832059473920

linkhttps://aacrjournals.org/mct calendar_today24-07-2018 13:55:48

2,2K Tweet

1,1K Takipçi

150 Takip Edilen

Molecular Cancer Therapeutics (@mct_aacr) 's Twitter Profile Photo
Molecular Cancer Therapeutics
@mct_aacr

3 months ago

Have a new drug candidate whose structure has not been reported in the literature? Submit your study as a First Disclosure article, which extends to all drug categories—including cell and gene therapies as well as novel combination approaches. brnw.ch/21wT5Jo

Have a new drug candidate whose structure has not been reported in the literature? Submit your study as a First Disclosure article, which extends to all drug categories—including cell and gene therapies as well as novel combination approaches. brnw.ch/21wT5Jo